Stoke Therapeutics, Inc. - Common Stock (STOK)
CUSIP: 86150R107
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,529,259
- Total 13F shares
- 20,216,239
- Share change
- -18,207,669
- Total reported value
- $680,314,450
- Put/Call ratio
- 63%
- Price per share
- $33.66
- Number of holders
- 96
- Value change
- -$703,085,149
- Number of buys
- 51
- Number of sells
- 43
Quarterly Holders Quick Answers
What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 86150R107:
Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ATP Life Science Ventures, L.P. |
13F
|
Company |
30%
|
17,161,713
|
$666,561,000 | — | 31 Mar 2021 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
6.3%
|
3,644,248
|
$141,543,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
5%
|
2,877,566
|
$111,765,000 | — | 31 Mar 2021 | |
| Redmile Group, LLC |
13F
|
Company |
4.4%
|
2,544,062
|
$98,811,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
1,661,011
|
$64,514,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
1,660,112
|
$64,480,000 | — | 31 Mar 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.5%
|
1,437,807
|
$55,844,000 | — | 31 Mar 2021 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
2.2%
|
1,265,950
|
$49,169,000 | — | 31 Mar 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.5%
|
872,264
|
$33,878,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
747,288
|
$29,025,000 | — | 31 Mar 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
671,978
|
$26,100,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
623,192
|
$24,205,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.97%
|
558,373
|
$21,687,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
293,036
|
$11,381,000 | — | 31 Mar 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.43%
|
250,000
|
$9,710,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.38%
|
216,935
|
$8,426,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.32%
|
186,660
|
$7,250,000 | — | 31 Mar 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.26%
|
150,729
|
$5,854,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.22%
|
127,366
|
$4,947,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.21%
|
122,360
|
$4,753,000 | — | 31 Mar 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
0.21%
|
120,000
|
$4,661,000 | — | 31 Mar 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.19%
|
108,823
|
$4,218,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
79,477
|
$3,087,000 | — | 31 Mar 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.11%
|
61,859
|
$2,403,000 | — | 31 Mar 2021 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.1%
|
58,264
|
$2,263,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
52,200
|
$2,027,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.09%
|
51,590
|
$2,004,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
51,180
|
$1,988,000 | — | 31 Mar 2021 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.08%
|
45,000
|
$1,748,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.08%
|
43,937
|
$1,707,000 | — | 31 Mar 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.06%
|
37,014
|
$1,438,000 | — | 31 Mar 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.06%
|
34,820
|
$1,352,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
32,330
|
$1,256,000 | — | 31 Mar 2021 | |
| AVIVA PLC |
13F
|
Company |
0.05%
|
30,266
|
$1,176,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
29,673
|
$1,152,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
25,000
|
$971,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.04%
|
24,600
|
$955,000 | — | 31 Mar 2021 | |
| Walleye Capital LLC |
13F
|
Company |
0.04%
|
24,100
|
$936,000 | — | 31 Mar 2021 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
20,600
|
$800,000 | — | 31 Mar 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
20,463
|
$795,000 | — | 31 Mar 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
18,100
|
$703,000 | — | 31 Mar 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
17,647
|
$686,000 | — | 31 Mar 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.03%
|
17,300
|
$672,000 | — | 31 Mar 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
15,507
|
$602,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
15,315
|
$595,000 | — | 31 Mar 2021 | |
| Birchview Capital, LP |
13F
|
Company |
0.03%
|
15,000
|
$583,000 | — | 31 Mar 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.03%
|
14,468
|
$562,000 | — | 31 Mar 2021 | |
| BAILARD, INC. |
13F
|
Company |
0.02%
|
14,100
|
$548,000 | — | 31 Mar 2021 | |
| HighVista Strategies LLC |
13F
|
Company |
0.02%
|
13,692
|
$532,000 | — | 31 Mar 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
13,200
|
$513,000 | — | 31 Mar 2021 |
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock (STOK) as of Q2 2021
As of 30 Jun 2021,
Stoke Therapeutics, Inc. - Common Stock (STOK) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,216,239 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Redmile Group, LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., Cormorant Asset Management, LP, GILDER GAGNON HOWE & CO LLC, STATE STREET CORP, FEDERATED HERMES, INC., and PERCEPTIVE ADVISORS LLC.
This page lists
96
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
104
Q2 2021 holders
96
Holder diff
-8
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.